Main Programme (DRAFT)

Day 1: 19 November

19 November 2024, Tuesday – Day 1
Time/Location	Peridot 201 – 203	Peridot 205 – 206
0800 Onwards	Registration
0845 – 0900	Welcome Address
0900 – 1000	Keynote 1: Pandemic Preparedness Prof Peiris, Joseph Sriyal Malik, The University of Hong Kong, Hong Kong SARPeridot 201 – 203
1010 – 1120	Symposium 1: Emerging and Zoonotic Infections	Symposium 2: Influenza and Other Respiratory Viruses 1
1010 – 1040	Can We Development A “Dream” Vaccine Against Coronaviruses? Prof Linfa Wang, Duke-NUS Medical School, Singapore	Long COVID: Epidemiology, Pathogenesis and Treatment Prof David Lye Chien Boon, National Centre for Infectious Diseases, Singapore
1040 – 1050	Are Antigen-Specific Vaccines Sufficient to Prevent Future Pandemics? Dr Tan Chee Wah, National University of Singapore, Singapore	Seasonal Influenza Vaccination for Children: A Cost-Effectiveness Analysis of Cell-Based versus Egg-Based Influenza Vaccine in Taiwan Prof Chia-Yu Chi, National Health Research Institutes, Taiwan
1050 – 1100	Genetic Dissection of Virus-Host Interactions in Bat Cells Dr Kam Leng Aw Yong, Duke-NUS Medical School,, Singapore
1100 – 1110	Severe Fever with Thrombocytopenia Syndrome (SFTS) Virus Infection: A Life-threatening Infection in Asia, A Perspective from Japan Prof Takeshi Tanaka, Nagasaki University Hospital, Japan	Cluster Of Acute Parvovirus B19 Cases Dec 2023-May 2024, Leicester, UK – Possible Post-COVID-19 Phenomenon? Dr Julian Wei-Tze Tang, University Hospitals of Leicester NHS Trust, United Kingdom
1110 – 1120	Abstract Talk 4	Abstract Talk 4
1120 – 1140	Coffee/Tea break, Exhibition & Posters viewing
1140 – 1250	Symposium 3: Influenza and Other Respiratory Viruses 2	Symposium 4: Viral Diagnostic
1140 – 1210	Talk Title TBC Prof Erik Karlsson, Institut Pasteur du Cambodge, Cambodia	Using AI/ML Approaches to Predict the Outcome of Infection in Ebola Virus and SARS-CoV-2 and Future Viral Evolution to Better Inform Medical Countermeasures Prof Julian A. Hiscox, University of Liverpool, United Kingdom
1210 – 1220	Identification of Residues in MERS-CoV Spike Receptor Binding Domain Implicated in Viral Entry and Immune Evasion Rachael Dempsey, University of Liverpool, United Kingdom	Evaluation and Comparison of Three High Throughput Assays (Abbott Alinity M, Hologic Aptima CMV Quant and Roche Cobas) for Quantifying CMV DNA in Plasma Samples Jodie D’Costa, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Australia
1220 – 1230	Human Parainfluenza Virus 3 Infection Elicits a Glycolytic Shift and Inflammatory Response in Human Nasal Epithelial Ciliated and Goblet Cells Dr Alan Hsu, Duke-NUS Medical School, Singapore	The Utility of Non-Molecular Diagnostic Tests for Common Herpesviruses in the Clinical Setting, A Tertiary Hospital Lab’s Perspective in Singapore Dr Wan Wei Yee, SingHealth, Singapore
1230 – 1240	Epithelial Responses to H5N1 Influenza Infection in An Influenza Airway Infection Model Dr Tan Kai Sen, National University of Singapore, Singapore	An Integrated Droplet Microfluidic Platform Capable of High-Throughput Functional Mab Screening Ajayanandan Yadunan, A*STAR Infectious Diseases Labs, Singapore
1240 – 1250	High-Yield Novel Chimeric Seasonal Influenza Virus-Like Particles (VLPs) Induced Potent Immune Responses and Protected Mice from Lethal Virus Challenges A T M Badruzzaman, National Health Research Institutes (NHRI) and National Central University (NCU), Taiwan	Abstract Talk 4
1250 – 1415	Lunch, Exhibition & Posters viewing
1415 – 1525	Symposium 5: Enteroviruses	Symposium 6: Transformative Technologies in Virus Research 1
1415 – 1445	Serological Perspectives on HFMD Vaccine Strategy: A Population-Based Study of EV-A71 and CVA16 in Chinese Children Prof Hongjie Yu, Fudan University, China	Potential Applications of Extracellular Vesicles as Anti-viral Agents and Carriers of Anti-viral Antisense Oligonucleotides Dr Le Thi Nguyet Minh, National University of Singapore, Singapore
1445 – 1455	Enterovirus A71 and Coxsackievirus A16: Epidemiology, Pathogenesis, and Vaccine Development Prof Yoke-Fun Chan, Universiti Malaya, Malaysia	Unraveling the Dynamics of Dengue: Integrating Antibody Profiling and Machine Learning for Enhanced Diagnosis and Severity Prediction A/Prof Tzong-Shiann Ho, National Cheng Kung University, Taiwan
1455 – 1505
1505 – 1515	Enterovirus A71 2A-S125A Serves as a Potential Candidate for an Attenuated Vaccine, Highlighting a Global Strategy in Enterovirus Vaccine Development Prof Yihong Peng, Peking University, China	Understanding the Enhanced Immune Responses to High-Density Microarray Patch Vaccination through Spatial Transcriptomics and Antibody Repertoire Analysis A/Prof David Muller, University of Queensland, Australia
1515 – 1525	Abstract Talk 2	Utilising Experimental Human Dengue Virus Infection Models to Advance Vaccine Development Prof Stephen Thomas, SUNY Upstate Medical University, United States
1525 – 1600	Coffee/Tea break, Exhibition & Posters viewing
1600 – 1700	Keynote 2: Emerging Infections Prof Zhengli Shi, Wuhan Institute of Virology, ChinaPeridot 201 – 203

Day 2: 20 November

20 November 2024, Wednesday – Day 2
Time/Location	Peridot 201 – 203	Peridot 205 – 206
0830 Onwards	Registration
0900 – 1000	Keynote 3: Virus Surveillance and Public Health Intervention Prof Leo Yee Sin, National Centre for Infectious Diseases, SingaporePeridot 201 – 203
1010 – 1120	Symposium 7: Innovations in Vaccine Research 1	Symposium 8: Viral Pathogenesis
1010 – 1040	COVID-19 Vaccines: Timing, Protection and Off-target Effects Prof Stephen Kent, The University of Melbourne, Australia	Role of Internal Ribosomal Entry Site-Driven Translation on Neurovirulence of Picornaviruses Prof Shin-Ru Shih, Chang Gung University, Taiwan
1040 – 1050	Systems Vaccinology of the BNT162b2 mRNA Vaccination in Healthy and Type 1 Diabetes Teenagers A/Prof Ching-Fen Shen, National Cheng Kung University, Taiwan	Overlying Particle Deposition Patterns onto Viral Receptor Distributions May Indicate Potential Spectrum of Clinical Disease Severity for Novel Airborne Respiratory Virus Infections Dr Julian Wei-Tze Tang, University Hospitals of Leicester NHS Trust, United Kingdom
1050 – 1100		Cross-Species Evolution of IFITM3 Antiviral Function Dr Aaron Irving, Zhejiang University School of Medicine, China
1100 – 1110	Development of A Safe and Efficient Self-Amplifying RNA Vaccine Thomas Vallet, A*STAR/Infectious Diseases Labs, Singapore	SARS-CoV-2 ORF3a and Exosomes Mediate Distal Organ Dysfunction in COVID-19 Dr Liang Qiming, Shanghai Jiao Tong University School of Medicine, China
1110 – 1120	Abstract Talk 2	Mechanical Transmission of Dengue Virus by Aedes Aegypti May Influence Disease Transmission Dynamics Dr Chen Chun-Hong, National Health Research Institutes, Taiwan
1120 – 1140	Coffee/Tea break, Exhibition & Posters viewing
1140 – 1250	Symposium 9: Innovations in Vaccine Research 2	Symposium 10: Blood Borne Viruses
1140 – 1210	Human Antibody Response to SARS-CoV-1 and SARS-CoV-2: Implication for the Development of Next-Generation Antibody Drugs and Vaccines Prof Zhang Linqi, Tsinghua University, China	Talk Title TBC Prof Dato’ Dr Adeeba Kamarulzaman, Monash University Malaysia, Malaysia
1210 – 1220	Effector Memory T Cells Induced After Prime/Boost Vaccination with Cytomegalovirus Vectors Against Conserved Influenza A Virus Antigens Protect Cynomolgus Macaques from Lethal, Aerosolised, Heterologous Challenge Dr Daniel Malouli, Oregon Health & Science University, United States	Activation of BMP Signaling is Essential for Efficient Hepatitis B Virus Replication and Leads to Association of Smad1/5 With Viral cccDNA Minichromosome in the Nucleus Prof Tan Yee Joo, National University of Singapore, Singapore
1220 – 1230	Evaluation of Dengue Immunity of Subjects in Singapore 5 Years Post-Third Dose of Dengvaxia Vaccine Using FcVR-Expressing Cells A/Prof Helen Oh, Chang General Hospital, Singapore	PRMT3, A Novel Target for Anti-HIV-1 Infections A/Prof Yu Dan, Beijing Children’s Hospital, China
1230 – 1240	A Dendritic Cell-Targeting Approach to Deliver A Universal Influenza Vaccine Candidate to The Respiratory Mucosa Daryl Lee, National University of Singapore, Singapore	Abstract Talk 3
1240 – 1250	Next-Generation Vaccines: Genome Recoded Zika virus Live Attenuated Vaccine Induces Sterilising Immunity and Maternal-Fetal Protection Aw Zhen Qin, National University of Singapore, Singapore	Abstract Talk 4
1250 – 1415	Lunch, Exhibition & Posters viewing
1415 – 1525	Symposium 11: Prevention and Control of Viral Infections	Symposium 12: Transformative Technologies in Virus Research 2
1415 – 1445	Future-Proofing Pandemic Response: Bridging Scientific Gaps with Mucosal Vaccines and Lessons from a Live Attenuated COVID-19 Vaccine Prof Suresh Mahalingam, Griffith University, Australia	Talk Title TBC Prof Marco Vignuzzi, A*STAR Infectious Diseases Lab, Singapore
1445 – 1455	Glycyrrhizic Acid Methyl Ester Conjugates Target the Main Protease, Demonstrating Antiviral Efficacy Against Wild-Type and Nirmatrelvir-Resistant Variants of SARS-CoV-2 Prof Cheng-Wen Lin, China Medical University, Taiwan	Using Epidemiological Findings to Efficiently Prevent and Control Epidemics of Major Viral Diseases in Taiwan: Implications for the Global Control of COVID-19 Dr Chwan-Chuen King, Institute of Epidemiology, Taiwan
1455 – 1505		S2 Antibody Mapping Utilising a Deep Mutational Scanning Approach Dr Weikang Nicholas Lin, A*STAR, Singapore
1505 – 1515	Unveiling the Robust Antiviral Action of MARVAS26 Against Picornaviruses Through Enteroviral VP1 and Sequestosome-1 Signaling Dr Thinesshwary Yogarajah, National University of Singapore, Singapore	Engineering Antiviral Immune-Like Systems for Autonomous Virus Detection and Inhibition in Mice Dr Yidan Wang, National University of Singapore, Singapore
1515 – 1525	Abstract Talk 2	Abstract Talk 4
1525 – 1600	Coffee/Tea break, Exhibition & Posters viewing
1600 – 1700	Keynote 4: Prevention and Control of Viral Infections Prof Kei Sato, The University of Tokyo, JapanPeridot 201 – 203

Day 3: 21 November

21 November 2024, Thursday – Day 3
Time/Location	Peridot 201 – 203	Peridot 205 – 206
0830 Onwards	Registration
0900 – 1000	Keynote 5: Pathogenesis and Immunology Prof Benhur Lee, Icahn School of Medicine at Mount Sinai, United StatesPeridot 201 – 203
1010 – 1120	Symposium 13: Pathogenesis and Immunology	Symposium 14: Vector Borne viruses 1
1010 – 1040	Dynamics of CD8+ T Cell Immunity to Circulating and Pandemic Viruses Dr Carolien Van de Sandt, The University of Melbourne, Australia	Antiviral for Dengue and Other Viruses Prof Prasert Auewarakul, Mahidol University, Thailand
1040 – 1050	Antagonism of the cGAS-STING Mediated Antiviral Innate Immune Responses by SARS-CoV-2 Nsp15 Dr Hsin-Ping Chiu, Icahn School of Medicine at Mount Sinai, United States	Evolutionary Dynamics of Dengue Virus in Saudi Arabia and the Quest for Safe and Effective Vaccines Dr Mohammad Bashir Bello, King Abdullah International Medical Research Center (KAIMRC), Saudi Arabia
1050 – 1100	Longitudinal Analysis of Virus-Specific Memory T Cells in the Nasal Mucosa Sabrina Ottolini, Duke NUS Medical School, Singapore
1100 – 1110	Structural Basis of Biased T Cell Recognition of Immune-Dominant Epitope of SARS-CoV-2 Spike Protein Dr Priyanka Chaurasia, Monash University, Australia	Revealing the Intracellular Trafficking of Dengue Virus RNA Genome A/Prof Ping Yueh-Hsin, National Yang Ming Chiao Tung University, Taiwan
1110 – 1120	Sexual Dimorphism Analysis Demonstrates Chemokine C–C Motif Ligand 2 Involvement in Enterovirus A71 Infection Pathogenesis Dr Huang Peng-Nien, Chang Gung University, Taiwan	Clinical Challenges in Dengue Dr Chia Po Ying, National Center for Infectious Diseases, Singapore
1120 – 1140	Coffee/Tea break, Exhibition & Posters viewing
1140 – 1250	Symposium 15: Host Pathogen Interaction	Symposium 16: Vector Borne viruses 2
1140 – 1210	Small Molecule-directed Protein Degradation As An Antiviral Strategy Prof Priscilla Li-ning Yang, Stanford University, United States	Dengue Pathogenesis – Beyond Antibody-dependent Enhancement Prof Eng Eong Ooi, Duke-NUS Medical School, Singapore
1210 – 1220	Antiviral Effect of Probiotics including Lacticaseibacillus Paracasei Strain Shirota Dr Tetsuji Hori, Yakult Honsha Co., Ltd., Japan	Two-Phase Interactome Analysis of Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus and Human Proteins Dr Hirotaka Takahashi, Nagasaki University, Japan
1220 – 1230		Genetic Analysis of Chikungunya Virus in Singapore in 2008-2024 Dr Grace Ngan, National Centre for Infectious Diseases, Singapore
1230 – 1240	Investigating the Roles of Plasminogen in Enterovirus A71 Infection Prof Chang Chuan-Fa, National Cheng Kung University, Taiwan	Low-Density Lipoprotein Receptor (LDLR) is Key Receptor of Crimean Congo Hemorrhagic Fever Virus Prof Ali Mirazimi, SVA, Sweden
1240 – 1250	Molecular Architecture of Coronavirus Double Membrane Vesicle Pore Complex Dr Ni Tao, The University of Hong Kong, Hong Kong SAR	Molecular Architecture of Chikungunya Virus Replication Complexes for Antiviral Therapeutic Development Dr Tan Yaw Bia, Nanyang Technological University, Singapore
1250 – 1415	Lunch, Exhibition & Posters viewing

1415 – 1525	Symposium 17: Water and Food Borne viruses	Virology Joint Satellite Symposium by the Taiwan Society of Virology and Vaccinology and National Cheng Kung University
1415 – 1445	Norovirus: Translation, Termination and Transmission Prof Jason Mackenzie, The University of Melbourne, Australia	Enterovirus
1445 – 1455	Increased Prevalence of Human Astrovirus Type 1 Infection in the Summer of 2022: An 8-Year Analysis Prof Hyun Soo Kim, Hallym University Dongtan Sacred Heart Hospital, Republic of Korea	1415 – 1435	Disruption of Calcium Homeostasis as an Inhibitory Mechanism for Enterovirus D68 Replication Prof Jim-Tong Horng, Chang Gung University, Taiwan
1455 – 1505	Investigating Human Circovirus (HcirV) Infection In Hong Kong Wu ShuSheng, The University of Hong Kong, Hong Kong SAR	1435 – 1455	Effect of Genetic Variations of Enterovirus A71 on Viral Properties and Pathogenesis Prof Jen-Ren Wang, National Cheng Kung University, Taiwan
1505 – 1515	Uncommon G3P[10] Rotavirus Strains Detected in Paediatric Patients with Acute Gastroenteritis in Thailand Nutthawadee Jampanil, Chiangmai University, Thailand	1455 – 1515	Mechanistic Insight into WWOX-Mediated Suppression of Enterovirus Infection Prof Li-Jin Hsu, National Cheng Kung University, Taiwan
1515 – 1525	Abstract Talk 4
1525 – 1600	Coffee/Tea break, Exhibition & Posters viewing
1600 – 1710	Symposium 18: Other Virus Infections of Medical Significance	Virology Joint Satellite Symposium by the Taiwan Society of Virology and Vaccinology and National Cheng Kung University
1600 – 1630	Detection of Emerging Pathogens in Wildlife in Cambodia Prof Veasna Duong, Institut Pasteur du Cambodge, Cambodia	Dengue Virus
1630 – 1640	Non-Polio Enterovirus Infections in Children and Neonates Presenting to Hospital Requiring Lumbar Puncture in Leicester, United Kingdom 2019-2023: Serotypes and Clinical Characteristics Dr Julian Wei-Tze Tang, University Hospitals of Leicester NHS Trust, United Kingdom	1600 – 1620	The Critical Role of Integrin Linked Kinase in Innate Responses to Dengue Virus Infection Prof Chih-Peng Chang, National Cheng Kung University, Taiwan
1640 – 1650	Hospitalisation Disease Burden of Varicella-Zoster Virus Infection in Post-Transplantation Pediatrics in China: The Imperative for Active Immunisation in Immunosuppressed Pediatric Populations A/Prof Yu Dan, Beijing Children’s Hospital, China	1620 – 1640	Enhanced Pathogenicity and Transmissibility of Dengue Virus Strains Prof Guann-Yi Yu, National Health Research Institutes, Taiwan
1650 – 1700	Abstract Talk 3	1640 – 1700	Uncovering Dengue Virus Host Factors: Paving the Way for Innovative Antiviral Strategies Prof Shin-Hong Shiao, National Taiwan University, Taiwan
1700 – 1710	Abstract Talk 4
1710 – 1725	Awards & Closing Ceremony Peridot 201 – 203